Dr. Sabine Kapasi
I’m thrilled to share that my latest article on public-private partnerships and the fight against tuberculosis has been featured in Financial Express (India). In the article, I explore the potential of PPPs in improving access to life-saving treatments for this neglected disease affecting poorer populations.
It’s been said that tuberculosis is the disease of poverty. But what if public-private partnerships could be the cure? Tuberculosis (TB) is one of the deadliest diseases in the world, claiming 1.4 million lives every year. Unfortunately, it is primarily a neglected disease affecting poorer populations. But what if public-private partnerships (PPPs) could change the game and help improve access to life-saving treatments? Let’s explore the potential of PPPs in the fight against TB.
The cost of patented TB drugs can be a significant burden for countries with a high burden of TB, such as India and South Africa. Initiatives such as the Stop TB Partnership’s Global Drug Facility and the Medicines Patent Pool have been working to negotiate lower prices for TB drugs and make them more widely available in low- and middle-income countries.